Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Archer Biosciences begins dosing in third cohort of TPI-287 trial in metastatic melanoma

July 21, 2010

Hexyl/methyl aminolevulinate photodynamic therapy does not damage cervical tissue

July 21, 2010

Ziopharm begins phase III palifosfamide trial in metastatic soft tissue sarcoma

July 21, 2010

Geron begins phase II imetelstat trial in advanced non-small cell lung cancer

July 20, 2010

Jevtana launched in U.S. for metastatic hormone-refractory prostate cancer

July 20, 2010

Health Canada clears phase III ReoT3D trial in head and neck cancer

July 20, 2010

FDA approves Lorus Therapeutics' IND for anticancer agent LOR-253

July 20, 2010

Amgen's denosumab BLA receives FDA priority review status

July 19, 2010

Chinese scientists identify novel protein kinase inhibitors

July 19, 2010

Merck KGaA identifies new tyrosine kinase inhibitors

July 16, 2010

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld
Parkinson’s disease is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder, and...
First-in-class pan-inflammasome blocker for hidradenitis suppurativa
BioWorld Science
Researchers from Paratus Sciences Corp. presented the preclinical profile of PS-1001, a novel pan-inflammasome inhibitor designed to prevent IL-1β and IL-18 release.
RX-10616 improves radiotherapy efficacy in HNSCC
BioWorld Science
Head and neck squamous cell carcinoma (HNSCC) accounts for high number of new diagnoses each year. Current management is based on surgery followed by radiotherapy...
CROI 2026: Neurodegeneration, the challenge of aging with HIV
BioWorld
Antiretroviral therapies against HIV have been in use for more than 30 years and have enabled people living with HIV to maintain undetectable viral levels. Many...